Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian CancerSetsuko K. Chambers, David S. Alberts, Haiyan Cui et al.|Clinical Cancer Research|2010Cited by 55
Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian CancerSetsuko K. Chambers, David S. Alberts, H.‐H. Sherry Chow et al.|Clinical Cancer Research|2012Cited by 32